跳至主要内容
临床试验/NCT01126671
NCT01126671已完成不适用

Clinical Trial of Vitamin D Supplementation in Healthy Adolescents

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
Baseline 25 Hydroxy Vitamin D (25OHD) Levels

研究概览

简要总结

This double blind, randomized controlled trial compares two supplemental doses of vitamin D in health adolescents.

详细描述

Vitamin D deficiency is a common problem. Currently, data do not support a recommended vitamin D supplementation dose for health adolescents to maintain normal vitamin D levels. This double blind, randomized controlled 12 week trial compares the use of two supplemental doses of vitamin D in this population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
11 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 11-18 years old

排除标准

  • chronic disease
  • use of medication known to effect bone or vitamin D metabolism
  • abnormal vitamin D or calcium at screening
  • body mass index <5% or >95%

研究组 & 干预措施

Low Dose Vitamin D

Active Comparator

Subjects are randomized to take 200 IU vitamin D3 daily in this arm.

干预措施: Supplemental Vitamin D (Drug)

High Dose Vitamin D

Active Comparator

Subjects are randomized to take 1000 IU vitamin D3 daily in this arm.

干预措施: Supplemental Vitamin D (Drug)

结局指标

主要结局

Baseline 25 Hydroxy Vitamin D (25OHD) Levels

时间窗: Baseline

25OHD will be drawn at baseline prior to starting vitamin D supplementation.

Follow-up 25OHD Levels

时间窗: 12 weeks

After 11weeks of treatment, repeat 25OHD levels will be drawn to assess subject response to vitamin D supplementation.

次要结局

  • Baseline Assessment of Bone Markers(Baseline)
  • Assessment of Bone Markers at Follow-up(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Pitts

Attending Physician

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验